Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 313751, 5 pages
http://dx.doi.org/10.1155/2013/313751
Editorial

Acupuncture and Herbal Medicine for Cancer Patients

1HanseMerkur Center for Traditional Chinese Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
2Department of Clinical Oncology, College of Korean Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea
3Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, StaudingerWeg 5, 55128 Mainz, Germany
4Department of Medical Oncology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan

Received 27 October 2013; Accepted 27 October 2013

Copyright © 2013 S. Schröder et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, C. DeSantis, K. Virgo, K. Stein, A. Mariotto, and T. Smith, “Cancer treatment and survivorship statistics, 2012,” CA Cancer Journal for Clinicians, vol. 62, pp. 220–241, 2012. View at Google Scholar
  2. M. Malvezzi, P. Bertuccio, F. Levi, C. La Vecchia, and E. Negri, “European cancer mortality predictions for the year 2013,” Annals of Oncology, vol. 24, no. 3, pp. 792–800, 2013. View at Google Scholar
  3. J. S. Temel, J. A. Greer, A. Muzikansky et al., “Early palliative care for patients with metastatic non-small-cell lung cancer,” The New England Journal of Medicine, vol. 363, no. 8, pp. 733–742, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Ernst and B. R. Cassileth, “The prevalence of complementary/alternative medicine in cancer: a systematic review,” Cancer, vol. 83, no. 4, pp. 777–782, 1998. View at Google Scholar
  5. H. Boon, J. B. Brown, A. Gavin, M. A. Kennard, and M. Stewart, “Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use,” Qualitative Health Research, vol. 9, no. 5, pp. 639–653, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. T. G. Liu, S. Q. Xiong, Y. Yan, H. Zhu, and C. Yi, “Use of Chinese herb medicine in cancer patients: a survey in Southwestern China,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 769042, 7 pages, 2012. View at Publisher · View at Google Scholar
  7. Y.-C. Lam, C.-W. Cheng, H. Peng, C.-K. Law, X. Huang, and Z. Bian, “Cancer patients' attitudes towards Chinese medicine: a Hong Kong survey,” Chinese Medicine, vol. 4, article 25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Yang, L.-Y. Chien, and C.-J. Tai, “Use of complementary and alternative medicine among patients with cancer receiving outpatient chemotherapy in Taiwan,” Journal of Alternative and Complementary Medicine, vol. 14, no. 4, pp. 413–416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Kim, S. D. Lee, D. R. Kim et al., “Use of complementary and alternative medicine among Korean cancer patients,” Korean Journal of Internal Medicine, vol. 19, no. 4, pp. 250–255, 2004. View at Google Scholar · View at Scopus
  10. I. Hyodo, N. Amano, K. Eguchi et al., “Nationwide survey on complementary and alternative medicine in cancer patients in Japan,” Journal of Clinical Oncology, vol. 23, no. 12, pp. 2645–2654, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. K. M. Field, M. A. Jenkins, M. L. Friedlander et al., “Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer,” European Journal of Cancer, vol. 45, no. 4, pp. 551–560, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Molassiotis, P. Fernandez-Ortega, D. Pud et al., “Use of complementary and alternative medicine in cancer patients: a European survey,” Annals of Oncology, vol. 16, no. 4, pp. 655–663, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. B. R. Cassileth and A. J. Vickers, “High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care,” Journal of Clinical Oncology, vol. 23, no. 12, pp. 2590–2592, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. K. M. Kelly, “Complementary and alternative medical therapies for children with cancer,” European Journal of Cancer, vol. 40, no. 14, pp. 2014–2016, 2004. View at Google Scholar
  15. P. M. Barnes, B. Bloom, and R. L. Nahin, “Complementary and alternative medicine use among adults and children: United States, 2007,” National health statistics reports, no. 12, pp. 1–23, 2009. View at Google Scholar · View at Scopus
  16. L. Downey, P. T. Tyree, and W. E. Lafferty, “Preventive screening of women who use complementary and alternative medicine providers,” Journal of Women's Health, vol. 18, no. 8, pp. 1133–1143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. M. Gray, A. W. H. Tan, N. P. Pronk, and P. J. O'Connor, “Complementary and alternative medicine use among health plan members. A cross-sectional survey,” Effective Clinical Practice, vol. 5, no. 1, pp. 17–22, 2002. View at Google Scholar · View at Scopus
  18. R. L. Nahin, J. M. Dahlhamer, B. L. Taylor et al., “Health behaviors and risk factors in those who use complementary and alternative medicine,” BMC Public Health, vol. 7, article 217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. D. M. Upchurch, L. Chyu, G. A. Greendale et al., “Complementary and alternative medicine use among American women: findings from the National Health Interview Survey, 2002,” Journal of Women's Health, vol. 16, no. 1, pp. 102–113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Lawsin, K. DuHamel, S. H. Itzkowitz et al., “Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer,” Supportive Care in Cancer, vol. 15, no. 5, pp. 557–564, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. V. B. Konkimalla and T. Efferth, “Evidence-based Chinese medicine for cancer therapy,” Journal of Ethnopharmacology, vol. 116, no. 2, pp. 207–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Efferth and B. Kaina, “Toxicities by herbal medicines with emphasis to traditional Chinese medicine,” Current Drug Metabolism, vol. 12, no. 10, pp. 989–996, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Molassiotis, M. Browall, L. Milovics, V. Panteli, E. Patiraki, and P. Fernandez-Ortega, “Complementary and alternative medicine use in patients with gynecological cancers in Europe,” International Journal of Gynecological Cancer, vol. 16, supplement 1, pp. 219–224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. G. A. Saxe, L. Madlensky, S. Kealey, D. P. H. Wu, K. L. Freeman, and J. P. Pierce, “Disclosure to physicians of CAM use by breast cancer patients: findings from the women's healthy eating and living study,” Integrative Cancer Therapies, vol. 7, no. 3, pp. 122–129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Deng, B. R. Cassileth, and K. S. Yeung, “Complementary therapies for cancer-related symptoms,” Journal of Supportive Oncology, vol. 2, no. 5, pp. 419–426, 2004. View at Google Scholar · View at Scopus
  26. D. Alimi, C. Rubino, E. Pichard-Léandri, S. Fermand-Brulé, M.-L. Dubreuil-Lemaire, and C. Hill, “Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial,” Journal of Clinical Oncology, vol. 21, no. 22, pp. 4120–4126, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Yang, X. Li, X. L. Li et al., “Traditional Chinese medicine in cancer care: a review of case series published in the Chinese literature,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 751046, 8 pages, 2012. View at Publisher · View at Google Scholar
  28. J. M. Ezzo, M. A. Richardson, A. Vickers et al., “Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting,” Cochrane Database of Systematic Reviews, vol. 22, no. 2, pp. 138–141, 2006. View at Google Scholar
  29. S. L. Dibble, J. Luce, B. A. Cooper et al., “Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial,” Oncology Nursing Forum, vol. 34, no. 4, pp. 813–820, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. T. S. K. Mok, W. Yeo, P. J. Johnson et al., “A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity,” Annals of Oncology, vol. 18, no. 4, pp. 768–774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. P. A. S. Johnstone, Y. P. Peng, B. C. May, W. S. Inouye, and R. C. Niemtzow, “Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies,” International Journal of Radiation Oncology Biology Physics, vol. 50, no. 2, pp. 353–357, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. P. A. S. Johnstone, R. C. Niemtzow, and R. H. Riffenburgh, “Acupuncture for xerostomia: clinical update,” Cancer, vol. 94, no. 4, pp. 1151–1156, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Schroeder, G. Meyer-Hamme, and S. Epplée, “Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN)—a pilot study using neurography,” Acupuncture in Medicine, vol. 30, no. 1, pp. 4–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. W. T. Y. Loo, L. Jin, L. W. C. Chow, M. N. B. Cheung, and M. Wang, “Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients,” Expert Opinion on Investigational Drugs, vol. 19, supplement 1, pp. S91–S100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. J. Vickers, D. J. Straus, B. Fearon, and B. R. Cassileth, “Acupuncture for postchemotherapy fatigue: a phase II study,” Journal of Clinical Oncology, vol. 22, no. 9, pp. 1731–1735, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. C. P. Escalante, T. Grover, B. A. Johnson et al., “A fatigue clinic in a comprehensive cancer center design and experiences,” Cancer, vol. 92, supplement 6, pp. 1708–1713, 2001. View at Google Scholar · View at Scopus
  37. J. Filshie, K. Penn, S. Ashley, and C. L. Davis, “Acupuncture for the relief of cancer-related breathlessness,” Palliative Medicine, vol. 10, no. 2, pp. 145–150, 1996. View at Google Scholar · View at Scopus
  38. L. Y. Wong, C. K. Wong, P. C. Leung, and W. K. Lam, “The efficacy of herbal therapy on quality of life in patients with breast cancer: self-control clinical trial.,” Journal of Patient Preference and Adherence, vol. 4, pp. 223–229, 2010. View at Google Scholar
  39. K. K. L. Chan, T. J. Yao, B. Jones et al., “The use of Chinese herbal medicine to improve quality of life in women undergoing chemotherapy for ovarian cancer: a double-blind placebo-controlled randomized trial with immunological monitoring,” Annals of Oncology, vol. 22, no. 10, pp. 2241–2249, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Molassiotis, J. Bardy, J. Finnegan-John et al., “Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial,” Journal of Clinical Oncology, vol. 30, no. 36, pp. 4470–4476, 2012. View at Google Scholar
  41. A. Enblom, A. Johnsson, M. Hammar, E. Onelöv, G. Steineck, and S. Börjeson, “Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea—a randomized controlled study,” Annals of Oncology, vol. 23, no. 5, pp. 1353–1361, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. J. P. Liu, M. Zhang, W. Y. Wang, and S. Grimsgaard, “Chinese herbal medicines for type 2 diabetes mellitus,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD003642, 2004. View at Google Scholar · View at Scopus
  43. W. C. S. Cho, “Scientific evidence on the supportive cancer care with chinese medicine,” Chinese Journal of Lung Cancer, vol. 13, no. 3, pp. 190–194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. S. G. Li, H. Y. Chen, C. S. Ou-Yang et al., “The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis,” PLoS One, vol. 8, no. 2, Article ID e57604, 2013. View at Google Scholar
  45. B. R. Cassileth, G. E. Deng, J. E. Gomez, P. A. S. Johnstone, N. Kumar, and A. J. Vickers, “Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition),” Chest, vol. 132, no. 3, pp. 340–354, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. J. Lee, Y. R. Jin, W. C. Lim et al., “Ginsenoside-Rb1 acts as a weak phytoestrogen in MCF-7 human breast cancer cells,” Archives of pharmacal research, vol. 26, no. 1, pp. 58–63, 2003. View at Google Scholar · View at Scopus
  47. J.-H. Kang, K.-H. Song, J.-K. Woo et al., “Ginsenoside Rp1 from panax ginseng exhibits anti-cancer activity by down-regulation of the IGF-1R/Akt pathway in Breast Cancer Cells,” Plant Foods for Human Nutrition, vol. 66, no. 3, pp. 298–305, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Motoo, I. Arai, I. Hyodo, and K. Tsutani, “Current status of Kampo (Japanese herbal) medicines in Japanese clinical practice guidelines,” Complementary Therapies in Medicine, vol. 17, no. 3, pp. 147–154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. H. A. Tindle, R. B. Davis, R. S. Phillips, and D. M. Eisenberg, “Trends in use of complementary and alternative medicine by us adults: 1997–2002,” Alternative Therapies in Health and Medicine, vol. 11, no. 1, pp. 42–49, 2005. View at Google Scholar · View at Scopus
  50. Y. Maimon, V. Karaush, N. Yaal-Hahoshen et al., “Effect of Chinese herbal therapy on breast cancer adenocarcinoma cell lines,” Journal of International Medical Research, vol. 38, no. 6, pp. 2033–2039, 2010. View at Google Scholar · View at Scopus
  51. S. Guan, W. Su, N. Wang, P. Li, and Y. Wang, “A potent tyrosinase activator from radix polygoni multiflori and its melanogenesis stimulatory effect in B16 melanoma cells,” Phytotherapy Research, vol. 22, no. 5, pp. 660–663, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. C.-C. Lin, C.-L. Kuo, M.-H. Lee et al., “Extract of Hedyotis diffusa Willd influences murine leukemia WEHI-3 cells in vivo as well as promoting T- and B-cell proliferation in leukemic mice,” In Vivo, vol. 25, no. 4, pp. 633–640, 2011. View at Google Scholar · View at Scopus
  53. R. Min, J. Tong, Y. Wenjun et al., “Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by Shikonin was partly through the inactivation of NF-κB pathway,” Phytotherapy Research, vol. 22, no. 3, pp. 407–415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. D. M. Eisenberg, E. S. J. Harris, B. A. Littlefield et al., “Developing a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biological evaluation—rationale, methods and preliminary results from a Sino-American collaboration,” Fitoterapia, vol. 82, no. 1, pp. 17–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. Q. Luo, Y. Cai, J. Yan, M. Sun, and H. Corke, “Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum,” Life Sciences, vol. 76, no. 2, pp. 137–149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Normile, “The new face of traditional Chinese medicine,” Science, vol. 299, no. 5604, pp. 188–190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. X. Y. Tian and L. Liu, “Drug discovery enters a new era with multi-target intervention strategy,” Chinese Journal of Integrative Medicine, vol. 18, no. 7, pp. 539–542, 2012. View at Google Scholar
  58. J.-J. Lu, W. Pan, Y.-J. Hu, and Y.-T. Wang, “Multi-target drugs: the trend of drug research and development,” PLoS ONE, vol. 7, no. 6, Article ID e40262, 2012. View at Google Scholar
  59. I. Raskin and C. Ripoll, “Can an apple a day keep the doctor away?” Current Pharmaceutical Design, vol. 10, no. 27, pp. 3419–3429, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. B. M. Schmidt, D. M. Ribnicky, P. E. Lipsky, and I. Raskin, “Revisiting the ancient concept of botanical therapeutics,” Nature Chemical Biology, vol. 3, no. 7, pp. 360–366, 2007. View at Publisher · View at Google Scholar · View at Scopus